HomeProductsBioactive CompoundsGPCR & G Protein TargetsProstaglandin ReceptorEvatanepag
Chemical structure of CAS 223488-57-1

Evatanepag

In Stock•Starting at $19 for 1 mg•Purity ≥ 98%
CAS No.223488-57-1
MDL No.MFCD09833940
MFC25H28N2O5S
MW468.60
InChI KeyWOHRHWDYFNWPNG-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$19In Stock
5 mg98%$21In Stock
10 mg98%$40In Stock
25 mg98%$61In Stock
100 mg98%$238In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Evatanepag is a monocarboxylic acid.

CAS No.223488-57-1
Product NameEvatanepag

Biological Targets

PTGER2

Associated Conditions

tibia fracture
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.

Bioorganic & medicinal chemistry letters • Vol. 19, Issue 7 • 2009
PMID: 19250823DOI: 10.1016/j.bmcl.2009.01.059

CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 36, Issue 10 • 2008
PMID: 18653741DOI: 10.1124/dmd.108.022897

In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.

Life sciences • Vol. 82, Issue 3-4 • 2008
PMID: 18155068DOI: 10.1016/j.lfs.2007.11.002

Documentation

Similar Products